View of Expensive molecular therapies for rare genetic disorders: carrier detection or newborn screening should be the strategy. A personal opinion.

Return to Article Details Expensive molecular therapies for rare genetic disorders: carrier detection or newborn screening should be the strategy. A personal opinion. Download Download PDF